Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of selective kinase inhibitors. Its structure supports the creation of bioactive molecules with enhanced metabolic stability and binding affinity. Commonly employed in medicinal chemistry for constructing advanced intermediates in drug discovery programs targeting oncology and inflammatory diseases. The presence of amine, fluoro, and methoxy groups allows for multiple derivatization pathways, making it valuable in building complex heterocyclic systems.